Comparison of side effect rates between IVIG and SCIG in a tertiary neurology centre
Tobias Rogers, Laura White, Ryan Yann Keh, Hannah Smith et autres
Background Intravenous immunoglobulin (IVIg) and subcutaneous immunoglobulin (SCIg) are used in the management of various neuroinflammatory conditions. IVIG is associated with potentially serious side effects (SEs), in particular venous thromboembolic events such as deep vein thrombosis (DVT) and pulmonary embolism (PE), and …